Muir-Torre syndrome

Dermatology Online Journal

Volumn 12, Issue 5, 2006, Pages

  Navi, Daniel ^a   Wadhera, Akhil ^a   Fung, Maxwell A ^a   Fazel, Nasim ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ANAMNESIS; ARTICLE; CASE REPORT; CLINICAL FEATURE; GENODERMATOSIS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MUIR TORRE SYNDROME; SKIN BIOPSY; ADENOCARCINOMA; ADENOMA; DNA REPAIR; GASTROINTESTINAL TUMOR; GENETICS; MIDDLE AGED; MUTATION; PATHOLOGY; SEBACEOUS GLAND TUMOR; SQUAMOUS CELL CARCINOMA; SYNDROME;

CARRIER PROTEIN; MLH1 PROTEIN, HUMAN; MSH2 PROTEIN, HUMAN; NUCLEAR PROTEIN; PROTEIN MSH2;

ADENOCARCINOMA, SEBACEOUS; ADENOMA; CARCINOMA, SQUAMOUS CELL; CARRIER PROTEINS; DNA REPAIR; GASTROINTESTINAL NEOPLASMS; HUMANS; MALE; MIDDLE AGED; MUTATION; MUTS HOMOLOG 2 PROTEIN; NUCLEAR PROTEINS; SEBACEOUS GLAND NEOPLASMS; SYNDROME;

EID: 33749183883     PISSN: 10872108     EISSN: 10872108     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Schwartz RA, Torre DP. The Muir-Torre syndrome: a 25-year retrospect. J Am Acad Dermatol. 1995 Jul; 33(1): 90-104.
2. Akhtar S, Oza KK, Khan SA, Wright J. Muir-Torre syndrome: case report of a patient with concurrent jejunal and ureteral cancer and a review of literature. J Am Acad Dermatol. 1999 Nov;41(5 Pt 1):681-6.
3. Cohen PR, Kohn SR, Kurzrock R. Association of sebaceous gland tumors and internal malignancy: the Muir-Torre syndrome. Am J Med. 1991 May;90(5):606-13.
4. Misago N, Narisawa Y. Sebaceous neoplasms in Muir-Torre syndrome. Am J Dermatopathol. 2000 Apr;22(2):155-61.
5. Burgdorg WH, Pitha J, Fahmy A. Muir-Torre syndrome: Histologic spectrum of sebaceous proliferations. Am J Dermatopathol. 1986 Jun;8(3):202-8.
6. Rutten A, Burgdorf W, Hugel H, Kutzner H, Hosseiny-Malayeri HR, Friedl W, Propping P, Kruse R. Cystic sebaceous tumors as marker lesions for the Muir-Torre syndrome: a histopathologic and molecular genetic study. Am J Dermatopathol. 1999 Oct;21(5):405-13.
7. Harrington CR, Egbert BM, Swetter SM. Extraocular sebaceous carcinoma in a patient with Muir-Torre syndrome. Dermatol Surg. 2004 May;30(5):817-9.
8. Finan MC, Connolly SM. Sebaceous gland tumors and systemic disease: a clinicopathologic analysis. Medicine (Baltimore). 1984 Jul; 63(4):232-42.
9. Lucci-Cordisco E, Zito I, Gensini F, Genuardi M. Hereditary nonpolyposis colorectal cancer and related conditions. Am J Med Genet A. 2003 Nov 1;122(4):325-34.
10. Mangold E, Pagenstecher C, Leister M, Mathiak M, Rutten A, Friedl W, Propping P, Ruzicka T, Kruse R. A genotype-phenotype correlation in HNPCC: strong predominance of msh2 mutations in 41 patients with Muir-Torre syndrome. J Med Genet. 2004 Jul; 41(7): 567-72.
11. Curry ML, Eng W, Lund K, Paek D, Cockerell CJ. Muir-Torre syndrome: role of the dermatopathologist in diagnosis. Am J Dermatopathol. 2004 Jun; 26(3): 217-21.
12. Kruse R, Ruzicka T. DNA mismatch repair and the significance of a sebaceous skin tumor for visceral cancer prevention. Trends Mol Med. 2004 Mar;10(3): 136-41.
13. Mathiak M, Rutten A, Mangold E, Fischer HP, Ruzicka T, Friedl W, Propping P, Kruse R. Loss of DNA mismatch repair proteins in skin tumors from patients with Muir Torre syndrome and MSH2 or MLH1 germline mutations: establishment of a immunohistochemical analysis as a screening test. Am J Surg Pathol. 2002 Mar; 26(3): 338-43.
14. Entius MM, Keller JJ, Drillenburg P, Kuypers KC, Giardiello FM, Offerhaus GJ. Microsatellite instability and expression of hMLH-1 and hMSH-2 in sebaceous gland carcinomas as markers of Muir-Torre syndrome. Clin Cancer Res. 2000 May;6(5): 1784-9.